Novartis AG
Common Stock · USD · NYSE
Price
$150.874
Cap
$195.43B
Earnings
—
30d Trend
+4.6%
20% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 71×Macro 0.99 (−1%)=70
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 60%
BRAIN47 HORIZON ANALYSIS
6-9 month opportunity — emerging trend
BRAIN47'S ASSESSMENT
I rate Novartis AG at 70/100 — a ELITE reading on the Brain47 Signal. The strongest factor is momentum at 82/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+5.9%
3 MONTHS
-7.5%
12 MONTHS
+38.6%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month opportunity — emerging trend. Momentum (82) and low-risk profile are the primary strengths. Historical volatility is normal at 20%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.